Just a reminder! Big pharmaceutical companies pay big dollars to biotech companies for good lipid delivery platforms.
BioVaxys may have the
best of these available to market. It may be just a matter of providing some better education and getting this information out to the public, the investment community and big pharma to let them know what the DPX delivery lipid delivery is all about and where they can get it!
Management knows that they have some significant work to do in this regard. But they are working hard to get the best message out! And now, the pharmaceutical industry has finally begun to listen!
BioVaxys President and Chief Operating Officer Kenneth Kovan says “We are pleased to join the RRPV consortium with organizations including Astra-Zeneca, Battelle, Deutsches Zentrum fr Infektionsforschung e.V. (The German Center for Infection Research),Genentech, Ginkgo Bioworks, Inc., Novavax and Leidos. We believe DPX can play a major role in the development of BARDA’s priority vaccine programs, and having the ability to collaborate with such world-renowned consortium members will no doubt be a significant benefit for the Company.” https://www.biovaxys.com/newsroom/biovaxys-to-participate-in-the-us-government-biomedical-advanced-research-and-development-authority-barda-rapid-response-partnership-vehicle-rrpv-vaccine-development-consortium And maybe the new Trump administration may make the rules for multiple phase drug trials a little less expensive and easier to accomplish! Certainly, any newly appointed drug czar appointed by Donald Trump may try to make the rules for some of these big drug trials necessary to get FDA approval a little less onerous and much less expensive to finish. I realize that since Trump was elected President that many in the investment community have been selling a lot their junior investment strategies and are presently chasing a virtual coin base investment like bitcoin, etherium or doge coin. A lot of big money is being made!
But eventually this part of the market will come back to reality when that market plunges back down. It always happens!
It is presently trading upwards on sentiment or wishful thinking! But why fight the trend while it remains your friend? But when that trend reverses quickly, a lot of money, can still be lost!
Why not return later to one of the best biotech opportunites out there?
Make another good investment decision!
Make your extra money and then reconsider investing in BioVaxys. We will wait! Not sure about the share price though!
Good investing to all!
All the best, Java
The following is a repeat of a lengthy BioVaxys presentation. But it's well worth a listen!